Literature DB >> 17470856

Combinations of tumor and treatment parameters are more discriminative for prognosis than the present TNM system in rectal cancer.

Iris D Nagtegaal1, Marleen J E M Gosens, Corrie A M Marijnen, Harm J Rutten, Cornelis J H van de Velde, J Han J M van Krieken.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 17470856     DOI： 10.1200/JCO.2005.05.4825

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  13 in total

1.  Clinical significance of magnetic resonance imaging findings in rectal cancer.

Authors:  Charles F Bellows; Bernard Jaffe; Lorenzo Bacigalupo; Salvatore Pucciarelli; Guiseppe Gagliardi
Journal:  World J Radiol       Date:  2011-04-28

2.  Expression of ITGB1 predicts prognosis in colorectal cancer: a large prospective study based on tissue microarray.

Authors:  Qi-Zhi Liu; Xian-Hua Gao; Wen-Jun Chang; Hai-Feng Gong; Chuan-Gang Fu; Wei Zhang; Guang-Wen Cao
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

3.  Gender-specific acute organ toxicity during intensified preoperative radiochemotherapy for rectal cancer.

Authors:  Hendrik A Wolff; Lena-Christin Conradi; Markus Schirmer; Tim Beissbarth; Thilo Sprenger; Margret Rave-Fränk; Steffen Hennies; Clemens F Hess; Heinz Becker; Hans Christiansen; Torsten Liersch
Journal:  Oncologist       Date:  2011-05-09

4.  MicroRNA-21 predicts response to preoperative chemoradiotherapy in locally advanced rectal cancer.

Authors:  Cristina Caramés; Ion Cristóbal; Víctor Moreno; Laura del Puerto; Irene Moreno; María Rodriguez; Juan P Marín; Andrea V Correa; Roberto Hernández; Víctor Zenzola; Tatiana Hernández; Ana León; José I Martín; Paloma Sánchez-Fayos; Damián García-Olmo; Federico Rojo; Ajay Goel; María J Fernandez-Aceñero; Jesús García-Foncillas
Journal:  Int J Colorectal Dis       Date:  2015-05-08       Impact factor: 2.571

5.  Prediction of tumor budding in patients with rectal adenocarcinoma using b-value threshold map.

Authors:  Fangying Chen; Shaoting Zhang; Xiaolu Ma; Yukun Chen; Zhen Wang; Yan Zhu; Chenguang Bai; Caixia Fu; Robert Grimm; Chengwei Shao; Jianping Lu; Fu Shen; Luguang Chen
Journal:  Eur Radiol       Date:  2022-08-23       Impact factor: 7.034

6.  High-grade acute organ toxicity during preoperative radiochemotherapy as positive predictor for complete histopathologic tumor regression in multimodal treatment of locally advanced rectal cancer.

Authors:  Hendrik Andreas Wolff; Jochen Gaedcke; Klaus Jung; Robert Michael Hermann; Hilka Rothe; Markus Schirmer; Torsten Liersch; Markus Karl Alfred Herrmann; Steffen Hennies; Margret Rave-Fränk; Clemens Friedrich Hess; Hans Christiansen
Journal:  Strahlenther Onkol       Date:  2009-12-28       Impact factor: 3.621

Review 7.  Pre-treatment carcinoembryonic antigen and outcome of patients with rectal cancer receiving neo-adjuvant chemo-radiation and surgical resection: a systematic review and meta-analysis.

Authors:  Giuseppe Colloca; Antonella Venturino; Pasquale Vitucci
Journal:  Med Oncol       Date:  2017-09-07       Impact factor: 3.064

8.  Dosimetric comparisons of VMAT, IMRT and 3DCRT for locally advanced rectal cancer with simultaneous integrated boost.

Authors:  Jun Zhao; Weigang Hu; Gang Cai; Jiazhou Wang; Jiang Xie; Jiayuan Peng; Zhen Zhang
Journal:  Oncotarget       Date:  2016-02-02

9.  MicroRNA-31 Emerges as a Predictive Biomarker of Pathological Response and Outcome in Locally Advanced Rectal Cancer.

Authors:  Cristina Caramés; Ion Cristobal; Víctor Moreno; Juan P Marín; Paula González-Alonso; Blanca Torrejón; Pablo Minguez; Ana Leon; José I Martín; Roberto Hernández; Manuel Pedregal; María J Martín; Delia Cortés; Damian García-Olmo; María J Fernández; Federico Rojo; Jesús García-Foncillas
Journal:  Int J Mol Sci       Date:  2016-06-03       Impact factor: 5.923

Review 10.  Systematic review and meta-analysis of the impact of tumour budding in colorectal cancer.

Authors:  A C Rogers; D C Winter; A Heeney; D Gibbons; A Lugli; G Puppa; K Sheahan
Journal:  Br J Cancer       Date:  2016-09-06       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.